WO2016073894A1 - Therapeutic agents with increased ocular retention - Google Patents

Therapeutic agents with increased ocular retention Download PDF

Info

Publication number
WO2016073894A1
WO2016073894A1 PCT/US2015/059539 US2015059539W WO2016073894A1 WO 2016073894 A1 WO2016073894 A1 WO 2016073894A1 US 2015059539 W US2015059539 W US 2015059539W WO 2016073894 A1 WO2016073894 A1 WO 2016073894A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
antibody
embodiments
seq id
il
Prior art date
Application number
PCT/US2015/059539
Other languages
French (fr)
Inventor
Michael March SCHMIDT
Joseph T. KOVALCHIN
Eric Steven Furfine
Original Assignee
Eleven Biotherapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201462077072P priority Critical
Priority to US62/077,072 priority
Priority to US201462087942P priority
Priority to US62/087,942 priority
Application filed by Eleven Biotherapeutics, Inc. filed Critical Eleven Biotherapeutics, Inc.
Publication of WO2016073894A1 publication Critical patent/WO2016073894A1/en

Links